



FOR ATOPIC ECZEMA AND PSORIASIS PATIENTS
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University Krems, Austria
Our experience in the treatment of over 20,000 atopic eczema
and psoriasis patients shows that besides allergic reactions to
foods an increasing number of pseudoallergic reactions caused
by toxic-irritative pollutants (formaldehyde, exhaust particles,
food additives, nicotine, wood preservatives, pesticides, heavy
metals) are responsible for the inflammatory process behind
the complex symptoms. Intrauterine and postnatal environ-
mental influences were also reported.
The routine analysis of specific IgE- and IgG4-factors in
atopic patients by means of ELISA-assays after challenge
meals (CM) showed an increased frequency of specific IgE-
and IgG4-antibodies after repeated CM. In 60% of the
patients, we simultaneously found raised concentrations of
circulating immune complexes with food specific IgE- and
IgG (p<0.005) responsible for the delayed (Type III)
allergic reactions in the same group.
Further inflammation markers like acute phase proteins
(α1-antitrypsin, α2-makroglobulin, haptoglobin and
caeruloplasmin) showed a surprisingly rapid increase
after CM (p<0.01) in the atopic group, by contrast the
control samples remained in the normal range.
Serum histamine levels (RIA-Test) also showed a
significant increase 1/2 h after CM and after individual
oral provocation with lactose, sucrose, tyramine, seroto-
nine or phenylethylamine, respectively. The carbohydrate
intolerance reactions (H2-test) were in good correlation
to the significantly lowered disaccharidase activities
(lactase, sucrase) in the gut of atopic eczema and
psoriasis patients (p<0.001). This was closely related to
chronic intestinal dysbiosis with toxic microbial break-
down products (alcohols, aldehydes, phenols, diamines)
leading to an increased intestinal permeability, histamine
release and impairment of liver detox function.
On the other side, we found both in atopic eczema and in
psoriasis patients pseudoallergic reactions against biogenic
amines and constantly raised serum histamine levels (also
in fasted patients), suggesting an inhibition of catabolic
enzymes (MAO, DAO, NMT). Previously published results
from our laboratory showed significantly reduced DAO
(p<0.001) and Type B MAO- (p<0.05) activities in
thrombocyte rich plasma of atopic eczema and psoriasis
patients explaining their intolerance reactions to histamine,
tyramine and octopamine rich foods.
Last, but not least, the chronic increased levels of free
radicals in whole blood and plasma of all patient groups
showed significant changes after oral intake of different
food homogenates/juices depending on their ROS-
blocking or ROS-increasing effects (enhanced chemilu-
minescence test).
Our current research shows that appropriate combinations
of hypoallergenic protein hydrolysates with selected sugar
alcohols and omega-3 fatty acids are dramatically enhancing
the anti-inflammatory and free radical quenching properties of
the mixture, demonstrating an obvious therapy effect in atopic
and psoriasis patients.
With the emergence of affordable microarray gene expression
profiling methods, the opportunity arises to ex-vivo test
certain nutraceutical combinations for their silencing ability
on inflammatory genes before and after their administration to
the patient (nutrigenomic evaluation).
The input of the above nutritional data in a computer
programme (FOOD ALLERGY CONTROL®) help us
generate personalized rotation diet plans that ensure a rapid
symptom improvement and stabilization of the clinical
course in both groups of patients.
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Lecture objectives
1. To recognize the crucial role of toxic-irritative pollu-
tants (pesticides, wood preservatives, food additives,
solvents, heavy metals, nicotine, exhaust particles, etc.)
and chronic infections as triggers of pseudoallergic
reactions and obligate cofactors of allergic answers to
food and respiratory allergens, respectively.
2. To understand the role of the above mentioned agents and
offending food in the free radical generation process with
subsequent activation of transcription families and acti-
vation of pro-inflammatory genes by means of appropri-
ate gene expression profiling methods.
3. To identify main players of the immune and inflamma-
tory response to food and food additives like specific
antibodies of IgE and IgG classes, acute phase proteins,
interleukins and other cytokines, prostaglandins, leuko-
triens, adhesion and coagulation factors.
4. To understand the specific food selection needed to
counteract the free radical generation and the inflam-
mation cascade in skin and atopic patients through
individualized diets.
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WOMEN’SHIGHERHEALTHRISKWITH INCREASED
N-6 PUFA INTAKE COMPARED TOMEN: AN ‘ISRAELI
GENDER PARADOX’ HYPOTHESIS
Shapira N
Institute for Nutrition Research, Rabin Medical Center
(Beilinson Hospital), Petah Tikvah, Israel
Israeli health status was found to be lower than in most
other Mediterranean countries, despite the ‘good’ Israeli
diet—low in calories and fat, and high in ratio of
polyunsaturated fatty acids (PUFA) to saturated fatty acids
(SFA), fruits, and vegetables. This unexpected dissociation
was defined as the ‘Israeli paradox’ and attributed to high
consumption of n-6 PUFA. However, gender analysis
showed that where women ranked unexpectedly low, i.e.
11th/15 European countries in life expectancy, whereas men
ranked among highest. This could suggest a gender
differential in health profiles with the same diet, which
appears to be concentrated mostly in cancer risk.
Trends of gender-specific risk were also observed in
comparisons of ethnic subgroups. Jewish women have had
much higher cancer prevalence (1:3) than Israeli-Arab
women (1:6) and much higher cancer mortality, with higher
dietary n-6 PUFA (mostly linoleic acid from corn and soy
oil), compared to n-9 monounsaturated fatty acids (MUFA,
mostly oleic acid from olive oil). However, Israeli-Arab
women recently have had a significantly faster-growing
rate, where men have remained relatively stable. This is
concurrent with dietary westernization, including exchanging
traditional olive oil for high n-6 PUFA oils (mostly soy),
resulting in increased n-6 PUFA consumption and high dietary
n-6:n-9 and n-6:n-3 FA ratios.
Experimental and clinical research have suggested sexual
dimorphism in lipid and PUFA metabolism and potential
carcinogenicity that may support the assumption regarding
women’s higher risk with a high n-6 PUFA diet. This can be
further adjunctive to genetic predisposition, as well as to
loss of the protective effects of olive oil against breast
cancer mutations.
Conclusions: This is the first time sexual dimorphism has been
suggested as a modulating factor of dietary effects on public
health and a national shift in disease epidemiology, linking
dietary ‘de-Mediterraneanization’ and high n-6 PUFA con-
sumption to western health risks. Supportive evidence suggests
that gender and/or genetic predisposition, previously suggested
to be the explanatory factor for high Israeli women’s cancer
risk, do not preclude a causal role of nutrition and its
preventive potential, but rather emphasizes its importance.
PREDICTIVE DIAGNOSTIC VALUE OF BIO-
MARKERS FOR RENAL FAILURE IN MEDICAL
EMERGENCY RELATIONSHIP OF NGAL (NEUTRO-
PHIL GELATINASE ASSOCIATED LIPOCALIN)
WITH UNDERWEIGHTNESS AND MALNUTRITION
Martines GF, Pirri C, Trovato F, Toro S, Tonzuso A,
Carpinteri G, Catalano D, Trovato G
MCAU e Diagnostica e Terapia Medica—Azienda
Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”,
Università di Catania, Italy
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Among the new biomarkers of acute kidney injury,
NGAL (neutrophil gelatinase-associated lipocalin)
seems one of the most useful even in the emergency
room. Nonetheless, its predictive value for severe
acute kidney injury (AKI) is still uncertain. The
higher frequency of acute kidney injury in patients
arriving in the emergency department is one of the
main factors that lead to an increase of length of
hospitalization and mortality and hence to more
prolonged and higher health care costs. Although there
are enough validated criteria for the definition of the
stages of renal damage (AKIN classification, stages 1–
3) or with the RIFLE criteria (that define five classes),
there are no reliable criteria of predictability and risk.
Despite NGAL thresholds’ predictor for subsequent
acute kidney injury have been defined in various
disease, unfortunately studies that define the actual
risk in the subset of baseline normal renal function
values are still few.
The aim of this study is the assessment, in subjects without
a previous history of chronic renal failure, of the degree of
risk of renal injury-failure associated with abnormal
baseline NGAL.
Patients and methods: We studied 115 patients (M 64,
D 51), mean age 74.71±11.07 years that, at the time of
presentation-triage in the emergency department, were
classified as maximum or high priority for critical
respiratory events and dyspnea. Patients with actual or
previous chronic renal failure (GFR>90), i.e. before
the current admission, patients with cancer, obesity
(BMI>30), moderate to severe anemia (Hb <11 g/dl)
and fever—body temperature >38.5°C were excluded.
All patients were followed with clinical monitoring,
routine emergency blood tests, continuous blood pres-
sure and ECG monitoring. Chest x-ray and echocardio-
grams were performed at the admission, and
subsequently, whenever indicated. Baseline serum NGAL
was assayed, and was thereafter checked at 6, 12, 24, 48
and 72 h.
Statistical analysis: the degree of risk (Odds ratio) for
acute kidney injury was defined as a GFR decrease
below 60; correlation analysis vs. GFR changes of
NGAL, BMI, BNP, age and serum albumin were
performed individually. MLR models were used in order
to assess predictability of GFR decrease and of renal
failure.
Results: The Odds Ratio demonstrates an increased risk
of kidney injury in patients with higher NGAL (Odds
ratio 6.085, 95% CI 1.282 to 28.883), lower BMI (odds
ratio, 3.401; 95% CI 0.883 to 13.108) and serum
albumin below the normal values, and in patients with
higher BNP.
A significant direct correlation between NGAL and GFR was
observed as well.
By the MLR model, using the baseline measurements, GFR decrease
is explained by NGAL, BMI, Albumin and BNP.
BMI: Body Mass Index; The complete predictive model includes
BMI, NGAL, Diabetes, Systolic and Diastolic Blood Pressure
Weighted Least Squares Regression—Weighted by Age
Conclusions. Considering our results NGAL is confirmed
to be a valuable biomarker for acute kidney injury in
patients admitted to the emergency department. The
additional information provided by our study implies also
a significant prognostic power of concurrent measurements
related to malnutrition, and notably low albumin and
underweightness.
Table Stepwise Linear Regressions to GFR
GFR T6
R R2 F sig β p
0,679 0,461 16,249 <0,0001
BMI 0,508 <0,0001
NGALTime 0 −0,289 0,003
EPMA Journal (2011) 2 (Suppl 1):S157–S165 S159
TAILORED MEDICAL TREATMENTS IN OBESITY.
ADHERENCE TO THE MEDITERRANEAN DIET
PROMOTE A LOWER INFLAMMATORY PROFILE
AND MINOR INSULIN RESISTANCE AND LIPID
METABOLIC ALTERATIONS
Pirri C, Trovato FM, Tonzuso A, Pennisi A, Martines FG,
Trovato GM, Catalano D
Department of Internal Medicine—Medical Diagnostics
and Therapy—University of Catania, Italy
The Mediterranean diet, due to its association with low
morbidity and mortality for several chronic diseases, has
been recognized as a model of healthy eating. Epide-
miological studies and clinical interventions have shown
an effect of the Mediterranean Diet on metabolic and
inflammatory biomarkers. Therefore, it is conceivable
that the protective role of diet on these might be
mediated by two pathways involving concurrently
inflammation and metabolic abnormalities. Purpose of
the study is to assess whether increased adherence to
Mediterranean Diet in obesity is associated with differ-
ent clinical profiles in relation to inflammation and
metabolic aspects.
Patients and methods: We studied 208 patients (139 F and 69
M), overweight or obese, age 46.50±12.70, BMI 30.27±4.46,
referred for nutritional counseling. Exclusion criteria:
therapy-dependent diabetes, infectious diseases or can-
cer, rheumatic diseases, inflammatory-granulomatous and
autoimmune diseases, renal insufficiency (GFR <90 ml/min),
thyroid diseases. Mediterranean diet adherence was
assessed through one-week/one year Dietary Recall
Interview carried out by dietitians and taking into
account the criteria of the Mediterranean Diet Score
(AMDS: range 0–55). Subsequent dietary treatment was
accomplished by dietary prescriptions developed using a
specific software (Dietosystem®).
Results: A negative correlation between AMDS and CRP
(r=− 0.312, P<0.0001) was observed. Moreover, an
inverse correlation with serum lipids was also found:
Patients who have a greater adherence to a Mediterranean
diet have lower levels total cholesterol (r=−0.261, P<
0.0001), triglycerides (r=− 0.158, 0.023) and LDL choles-
terol (r=0.271, p<0.0001).
BMI: Body Mass Index; CRP: C Reactive Protein, AMDS: Adherence
Mediterranean Diet Score.
The Odds ratio also shows that high levels of adherence to
Mediterranean diet is associated with lower values of CRP
Table Multiple Linear Regressions to CRP and HOMA
CRP
R R2 F sig β p
0,465 0,216 10,996 <0,0001
BMI, Kg/m2 0,229 <0,001
HOMA 0,164 0,013
Total Cholesterol, mg/dl 0,000 0,994
Triglycerides, mg/dl 0,076 0,276
AMDS −0,289 <0,0001
HOMA
R R2 F sig β p
0,340 0,116 5,216 <0,0001
BMI, Kg/m2 0,127 0,084
Total Cholesterol, mg/dl −0,069 0,331
Triglycerides, mg/dl 0,175 0,017
AMDS 0,029 0,689
CRP, mg/L 0,185 0,013
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(OR: 0.132, CI 0.071–0.248), and insulin resistance (OR:
0.115, CI 0.039–0.338).
Conclusions: Our study suggests that adherence to tradi-
tional Mediterranean diet is associated with lower concen-
trations of at least one marker of inflammation and lipid
risk factors in subjects without significant cardiovascular
disease and without diabetes. This may partly explain the
beneficial effects of this dietary profile on various chronic
diseases, and confirms its probable role in secondary
prevention. The use of Mediterranean Diet is reasonably
to be advised and warranted also in obese subjects, due to
its association with a favorable inflammatory and lipid
metabolic profile, and lower insulin resistance.
PERSONALIZED NUTRITIONAL APPROACH
AS THE CORE TREATMENT FOR NAFLD.
GREATER ADHERENCE TO MEDITERRANEAN
DIET IS ATARGETED PREVENTION
Trovato FM, Pirri C, Tonzuso A, Pennisi A, Martines FG,
Trovato GM, Catalano D
Department of Internal Medicine—Section of Medical
Diagnostics and Therapy—University of Catania, Italy
NAFLD (Non-Alcoholic-Fatty Liver—Disease), because of
its association with obesity, diabetes and insulin resistance
(IR), can be considered the hepatic expression of metabolic
syndrome. Mediterranean d Diet is commonly recognized
as a behavioral, clinical and epidemiological paradigm of
healthy lifestyle.
The aim of this study is to assess relationship between
adherence to Mediterranean diet score (AMDS) and
NAFLD, a condition secondary to unhealthy eating habits,
reduced physical activity and genetic factors.
Methods: We studied 274 consecutive subjects (160 F, 114 M)
with a mean age of 46.21±12.88 years and BMI 30.33±5.98,
referred to our DH for nutritional counseling. Exclusion criteria
were the presence of viral hepatitis, toxic or autoimmune
disorders, alcohol abuse (less than 20 ml/day), diabetes, use of
hepatotoxic drugs, insulin resistance. This last was evaluated
by HOMA (Homeostasis Model—Assessment) and adherence
to Mediterranean Diet was assessed by a validated score
(AMDS: range: 0–55). Patients underwent ultrasonography of
the upper abdomen and severity of steatosis was assessed by
the Bright Liver Score (BLS). Dietary prescriptions were given
using a proprietary software—Dietosystem®—that allows
personalized recipes and lifestyle-physical activity counseling.
Results: Patients were 133 NAFLD and 141 non-NAFLD;
these were the control group, matched for age, sex and
physical activity (Baecke Questionnaire). A lower adher-
ence to the Mediterranean diet has been observed among
patients with NAFLD compared with controls (33, 51±3.82
vs. 35.62±4.42; p<0.0001). The two groups also differ for
BMI (33.31±5.32 vs. 27.55±5.21, P<0.0001) and HOMA
(4.33±3.85 vs. 2.03±0.90, p<0.0001) that are higher in
NAFLD subjects. There is an inverse correlation between
BLS and AMDS (r=−0.175, p: 0.004). In the linear
regression model, weighted by gender (AMDS lower in
women), BMI (p<0.0001), HOMA (p: 0.0004) and AMDS
(p<0.0001) explained together 55.1% of variance to BLS.
The Odds ratio shows that the risk of more severe liver steatosis
is increased by the greater degree of obesity (OR: 8.747, CI:
5.051 to 15.147), by higher values of CRP (OR 2.624, CI:
Multiple Linear Regressions to BLS
Predictors R R2 F Sig β p
0,742 0,551 17,677 <0,0001
BMI, Kg/m2 0,463 <0,0001
HOMA 0,291 0,004
AMDS −0,354 <0,0001
PCR, mg/L 0,067 0,427
AGE, y 0,082 0,312
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1.350 to 5.101) and HOMA (OR: 4.392, CI: 2.143 to 9.001),
and decreased by 50% from a greater degree of adherence to a
Mediterranean diet (OR: 0.575, CI: 0.354 to 0.835).
Conclusion: Greater adherence to Mediterranean diet is
associated with lower prevalence and severity of fatty liver.
Exercise and nutritional profiles consistent with the Mediter-
ranean diet, as in the case of the current guidelines, may
prevent this and other related conditions. A reasonable
therapeutic approach must include advices addressed at
qualitative dietary changes and focused at strategies targeted
for appropriate behavioral changes.
AD36 HUMAN ADENOVIRUS SEROPOSITIVITY.
A NOVEL OBESITY BIOMARKER ASSOCIATED
WITH ENHANCED RESPONSE TO DIETARY
INTERVENTIONS
Trovato GM, Martines GF, Pirri C, Trovato FM, Pace P,
Tonzuso A, Pennisi A, Toro S, Catalano D
1Department of Internal Medicine, Diagnostica e Terapia
Medica, Facoltà di Medicina e Chirurgia, Università di
Catania, Catania, Italy
Obesity and related or consequent disease are both currently
attributed to inappropriate lifestyle and nutrition. Higher
prevalence of human adenovirus Ad36 seropositivity
(Ad36+) is reported in obesity. This observation is mainly
epidemiological and the predictability of obesity on the basis
of Ad36 seropositivity is only conjectural. The aim of our
study is to investigate whether lifestyle-nutritional intervention
achieve different outcomes in obese patients, i.e. if they are
blunted or enhanced according to Ad36 seropositivity status.
Patients and methods: One-year nutritional intervention was
planned and accomplished for 62 overweight-obese patients,
studied by BIA and anthropometric nutritional assessment,
homeostatic model assessment of Insulin Resistance
(HOMA), and Ad36+ assay. Lower salt/lower calories
Mediterranean diet, physical activity increase, smoking
withdrawal and lifestyle counselling, contributed by the
support of an health psychologist, were provided. Subjects
attended a total of twenty scheduled individual encounters and
visits with one of the physicians, the dietician and the
psychologist for clinical evaluation during the first
6 months (1st–6th month) of follow-up. Suggestions
and advice on individual “healthy” food purchase,
storage and cooking are provided. Physical activity is
encouraged mainly in the form of walking using the
‘10,000 steps a day’ suggestion, and adherence is also
empowered by providing a portable electronic pedometer as a
motivational and control tool.
Results: Ad36 seropositive patients have baseline greater
BMI in comparison with Ad36 seronegative patients.
Different prevalence of post-interventional response, that
is significantly greater among Ad36+ patients, is
observed: there was a greater decrease of obesity,
assessed by BMI, and a greater reduction of insulin
resistance, assessed by HOMA. By Odds ratio, Ad36
seropositivity is associated with a positive response to
the nutritional intervention, i.e. higher prevalence of
favorable response to diet.
In Ad36 seronegative NAFLD patients, whose metabolic
profile, and notably, HOMA, improves without significant
weight loss, an effect of dietary changes profile and not
only of lowered food caloric intake is conceivably
operating.
A BMI adjusted Multiple-Linear-Regression model explains
significantly 23.8% (p<0.04) of the variance to significant
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weight loss and to lowering of HOMA, with the significant
contribution of Ad36 seropositivity.
Conclusion: Ad36+ obese patients, under dietary treat-
ment, have a more consistent decrease of Insulin
resistance and body weight, indicating a greater respon-
siveness to the nutritional intervention. Even if this can
be due to the initial greater obesity of Ad36 seropos-
itive patients, the subsequent Multiple Liner Regression
model, BMI adjusted for eliminating the difference of
BMI as a potential confounding factor, confirms the
seemingly beneficial relevance of Ad36 seropositivity.
This is not dependent on a greater pre-interventional
body weight. Ad36 previous infection seems to enhance
weight loss, and recovery of insulin sensitivity under
nutritional interventional treatment.
A PREDICTIVE DIAGNOSTIC SEROLOGICAL
BIOMARKER OF NAFLD AD37 HUMAN ADENO-
VIRUS AS A PUTATIVE CAUSATIVE FACTOR
Trovato GM1, Martines GF1, Pirri C1, Trovato FM1, Castro A2,
Garozzo A2, Catalano D1
1Department of Internal Medicine, Diagnostica e Terapia
Medica, Facoltà di Medicina e Chirurgia, Università di
Catania, Catania, Italy
2Department of Microbiological and Gynaecological Sci-
ences, Facoltà di Medicina e Chirurgia, Università di
Catania, Catania, Italy
A significant association of Ad-36 seropositivity with
obesity, with Non-Alcoholic-Fatty-Liver Disease
(NAFLD) and with essential Hypertension in human
beings is reported, but pathophysiology is still elusive.
Ad-36 adipogenic adenovirus effect cannot be directly
explained by an insulin-resistance-related mechanism
and in adolescents Ad-36 seropositivity is strongly
associated with lipid disorders regardless of obesity. A
different Adenovirus, Ad-37, increases adiposity in
animals.
NAFLD is a condition whose natural history is related
to, but not completely explained by over-nutrition,
obesity and insulin resistance. Its main feature is bright
liver, an Ultrasound pattern that encompasses mostly
fatty liver disease, irrespective of the actual causes. This
condition is currently assessed non-invasively and
ultrasound bright liver pattern and the derived score
have a satisfactory clinical consistency. Insulin Resis-
tance, commonly evaluated as HOMA, according to the
Homoeostasis Model Assessment of Insulin Resistance
index (HOMA or HOMA-IR), is a pathophysiological
clue to several metabolic-dependent conditions, includ-
ing obesity, hypertension, hyperlipidemia and type 2
diabetes. Despite increased highly sensitive C-reactive
protein (CRP) assay was found to be associated with
NAFLD and that it was suggested the use of CRP as a
sensitive independent marker to detect fatty liver in the
general population, a validated serological clue of
NAFLD is not yet available. Association of Adenovirus
Ad-36 seropositivity with obesity but not with Non-
Alcoholic-Fatty-Liver Disease (NAFLD) was previously
shown. The aim of this study is to investigated if non-
diabetic patients with Ad37+ seropositivity show
different prevalence of overweight-obesity, Insulin
Resistance, assessed by HOMA, higher CRP, and/or
of bright liver in comparison with Ad37-seronegative
patients.
Patients and methods: 268 adult non-diabetic patients
(men 146, women 122) referred for essential hyperten-
sion, overweight-obesity, and/or hyperlipidemia were
treated by lower salt/lower calories Mediterranean diet,
physical activity increase and smoking withdrawal
counselling by the support of an health psychologist;
Ad36-seropositive patients are excluded from data
analysis.
Results: 65/268 patients are Ad37+ seropositive and 82/
268 patients are both Ad37- and Ad36- seronegative.
Obesity prevalence, defined as BMI≥30, is not signifi-
cantly different in Ad37+ (11/65; 16.9%) vs. Ad37- seroneg-
ative (15/82; 18.2%) subjects;
Bright Liver is present in 22/65 (33.8%) Ad37+ seropos-
itive patients vs. 13/82 (15.8%) Ad37-seronegative patients
(p<0.019).
Odds Ratios show an increased hazard to Obesity
associated with greater insulin resistance and CRP, while
higher HDL-Cholesterol is associated with lower obesity
prevalence. A more consistent hazard of Ad37 seropos-
itivity is associated with NAFLD, along with greater
insulin resistance and CRP.
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BMI: Body Mass Index; FM: Fat Mass; HDL: High-density
lipoprotein; LDL: Low-density lipoprotein, CRP: C-Reactive Protein
Weighted Least Squares Regression—Weighted by Gender
Conclusion: Ad-37 seropositivity could be tentatively consid-
ered a hallmark of a clinical-metabolic profile associated with
Fatty liver and NAFLD also in non-obese patients.
MATCHING EGGCOMPOSITIONWITH PERSONAL
MEDICAL/METABOLIC RISK: A CASE STUDY
FOR A FUNCTIONAL NUTRITION APPROACH
TO PPPM
Shapira N
Institute for Nutrition Research, Rabin Medical Center
(Beilinson Hospital), Petah Tikva, Israel
Epidemiological and clinical studies linking egg consump-
tion to increased all-cause mortality, heart disease, and
diabetes have led medical doctors to warn against egg
consumption, especially in people with disease risk.
Linear regressions to BMI and HOMA
BMI
R R2 F sig β p
0,892 0,796 26,658 <0,0001











R R2 F sig β p
0,912 0,831 33,643 <0,0001







BMI, kg/m2 0,788 <0,0001
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However individual predisposition and dietary factors have
shown significant effect on this link, i.e. egg was found to
increase plasma cholesterol mostly in genetically-
predisposed ‘responders’ (33% of the population); much
higher increase in CVD risk with high egg intake was
found among diabetics; lack of increased LDL was
noted with 2eggs/day associated with reducing diet and
weight reduction. Beyond elevated plasma cholesterol
and LDL levels, high egg intake increased low-density
lipoprotein (LDL) oxidation (37% higher with two eggs/day
vs. 2–4/week), post-prandial lipemia (with >140 mg
cholesterol/meal), inflammation (elevated C-reactive protein,
amyloid A, adipose-tissue macrophages), fasting blood-
glucose, cardiovascular disease and all-cause mortality in
diabetics (two-fold), and new-onset diabetes.
Egg modification can address most of these effects, i.e. two
eggs/day with reduced n-6 polyunsaturated fatty acids
(PUFA) and increased n-9 monounsaturated fatty acids
(MUFA) and antioxidants (vitamin E, carotenoids, selenium)
reversed two/day regular egg-induced increased LDL oxida-
tion and fasting blood glucose to levels of 2–4 eggs/week;
one/day n-3 PUFA-fortified egg increased high-density
lipoprotein (HDL) levels, LDL particle size, and endothelial
function, and reduced plasma CRP, apolipoproteinB: apolipo-
proteinA1 ratio, triglycerides, hemoglobin A1c, and fasting
glucose/glycemic response.
Personalized diagnosis of genetic/metabolic predisposi-
tion and actual state could specify individual risk and
requirements. This could correspondingly direct the
optimal match for egg type, preparation, and meal-
planning, i.e. Greek/Mediterranean style (adding low n-6
PUFA eggs to a high n-3 PUFA, n-9 MUFA, and
antioxidant meal) vs. English/butter-and-bacon (adding
high n-6 ‘regular’ egg to saturated fat and red/processed meat
meal). This could have additional effects and further modify
egg-related physiopathological outcomes, for consumer ben-
efits vs. risks.
Matching personalized evaluation of metabolic/genetic
markers with the combined effect of egg composition/
preparation and meal content, as shown by postprandial
response, could best fit personal/sub-population needs and
enabling informed selection and constructive expansion of
egg consumption.
Most people will benefit by specified matching, though
consumption may remain advised against in some
metabolically/genetically-sensitive individuals.
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